Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
Łodyga M, Maciejewska K, Eder P, Waszak K, Stawczyk-Eder K, Michalak M, Dobrowolska A, Wiśniewska-Jarosińska M, Gąsiorowska A, Cicha M, Wierzba W, Rydzewska G. Łodyga M, et al. Among authors: waszak k. Pol Arch Intern Med. 2021 Mar 30;131(3):226-232. doi: 10.20452/pamw.15796. Epub 2021 Feb 5. Pol Arch Intern Med. 2021. PMID: 33544564 Free article.
Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A, Łykowska-Szuber L, Stawczyk-Eder K, Waszak K, Kucharski MA, Dobrowolska A, Eder P. Krela-Kaźmierczak I, et al. Among authors: waszak k. Pol Arch Intern Med. 2018 Aug 31;128(7-8):447-454. doi: 10.20452/pamw.4292. Epub 2018 Jul 11. Pol Arch Intern Med. 2018. PMID: 30057387 Free article.
Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
Krela-Kazmierczak I, Szymczak-Tomczak A, Tomczak M, Lykowska-Szuber L, Eder P, Kucharski MA, Stawczyk-Eder K, Waszak K, Karczewski J, Dobrowolska A. Krela-Kazmierczak I, et al. Among authors: waszak k. Arch Med Sci. 2018 Sep 5;17(3):662-674. doi: 10.5114/aoms.2018.78009. eCollection 2021. Arch Med Sci. 2018. PMID: 34025836 Free PMC article.
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
Lykowska-Szuber L, Walczak M, Skrzypczak-Zielinska M, Suszynska-Zajczyk J, Stawczyk-Eder K, Waszak K, Eder P, Wozniak A, Krela-Kazmierczak I, Slomski R, Dobrowolska A. Lykowska-Szuber L, et al. Among authors: waszak k. Front Immunol. 2021 Mar 9;12:615539. doi: 10.3389/fimmu.2021.615539. eCollection 2021. Front Immunol. 2021. PMID: 33767696 Free PMC article.
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
Cichoż-Lach H, Michalak A, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Waszak K, Talar-Wojnarowska R, Zatorski H, Solarska-Półchłopek A, Chmielnicki J, Filip R, Pękala A, Janiak M, Skrobot K, Kasińska E, Krogulecki M, Królikowski P, Kłopocka M, Liebert A, Poniewierka E, Smoła I, Gąsiorowska A, Kaczka A, Wypych J, Wojciechowski K, Drygała S, Zagórowicz E. Cichoż-Lach H, et al. Among authors: waszak k. Therap Adv Gastroenterol. 2021 Aug 30;14:17562848211036456. doi: 10.1177/17562848211036456. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34484422 Free PMC article.
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).
Liebert A, Kłopocka M, Michalak A, Cichoz-Lach H, Talar-Wojnarowska R, Domz Ał-Magrowska D, Konecki Ł, Filipiuk A, Krogulecki M, Kopertowska-Majchrzak M, Stawczyk-Eder K, Waszak K, Eder P, Zagórowicz E, Smoła I, Wojciechowski K, Drygała S. Liebert A, et al. Among authors: waszak k. Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241293938. doi: 10.1177/17562848241293938. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39575158 Free PMC article.
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Eder P, Kłopocka M, Cichoż-Lach H, Talar-Wojnarowska R, Kopertowska-Majchrzak M, Michalak A, Filip R, Waszak K, Stawczyk-Eder K, Janiak M, Skrobot K, Liebert A, Zatorski H, Solarska-Półchłopek A, Krogulecki M, Pękała A, Poniewierka E, Smoła I, Kaczka A, Wojciechowski K, Drygała S, Zagórowicz E. Eder P, et al. Among authors: waszak k. Therap Adv Gastroenterol. 2023 Feb 14;16:17562848231151295. doi: 10.1177/17562848231151295. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36818601 Free PMC article.
A new ecotoxicological test method for genetically modified plants and other stressors in soil with the black fungus gnat Bradysia impatiens (Diptera): current status of test development and dietary effects of azadirachtin on larval development and emergence rate.
Jänsch S, Bauer J, Leube D, Otto M, Römbke J, Teichmann H, Waszak K. Jänsch S, et al. Among authors: waszak k. Environ Sci Eur. 2018;30(1):38. doi: 10.1186/s12302-018-0167-8. Epub 2018 Sep 27. Environ Sci Eur. 2018. PMID: 30370193 Free PMC article.
12 results